Biomarkers in Neuropsychiatry
SJR0.795
NL
NLJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.795 | Q2 | 77.0% | |
| 2024 | — | — | 0.603 | Q2 | 68.6% | |
| 2023 | — | — | 0.874 | Q2 | 82.2% | |
| 2022 | — | — | 0.954 | Q2 | 85.2% | |
| 2021 | — | — | — | 9.8% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2666-1446
country
NLcoverage
2019-2025